Outset Medical insider plans NASDAQ stock sale
Outset Medical (OM) has a notice of proposed sale of common stock by reporting person John Brottem.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Outset Medical (OM) has a notice of proposed sale of common stock by reporting person John Brottem. The filing lists 2,562 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on August 17, 2026, with an aggregate market value of $11,549.17. It also notes the settlement of 5,033 vested restricted stock units as equity compensation for services rendered, with the same August 17, 2026 date. In the prior three months, the reporting person sold 2,638 shares of common stock on May 15, 2026 for $9,760.60.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Units financial
Equity Compensation financial
Securities Sold During The Past 3 Months regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock sale is disclosed in Outset Medical (OM)'s Form 144?
Who is the reporting person in the Outset Medical (OM) Form 144 filing?
What equity compensation is reported for Outset Medical (OM) in this filing?
What prior stock sales by the reporting person are disclosed for OM?
On which market is the Outset Medical (OM) stock involved in this Form 144 listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.